The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just topped up
Expect good times this year
Yes -totally agree
RBC target 60p
Expect that to be a minimum
imho dyor
Big money to be made here if you have patience time to hold new CFO is not here for a jolly with his credentials
Fully expect contract news with hospitals uk And overseas shortly .
Imho tbis could be a £1 stock if the company gets contracts imho .
Possitive cash flow so no need for more fundraising
imho - dyor
10.188-10.84
Looks good here chart wise breaking out someone got a sniff of good news inbound ?
Like the new heavyweight CFO said creating shareholder value ECT
Nobody is selling this right now it's a unique opportunity imho to create some meaningful returns
You guys , really , first thing you will find with any rises in that these will be short lived .
The recent placees will sell into snippets of good news to slice the holdings which will be not revenue enhancing yet
The phase 3 trials and working capital will require more money especially if it continues into next year , however the funding may not necessary be dilution . The only thing that will My mind is if the current pilots turn into large re-occurring commercial contracts
Funny how folks invest sometimes, they wait for a move before buying but do little research on the prospects for that very rise .
1 bag and potentially over £1 here this year amigo
Gl all
Looking at he possibilities in USA will be the big one though
Results of trials at NHS hospital should be due soon. Maybe someone has got a sniff of the outcome and getting in before news release. Would be nice...
Soon
Lots of news due be interesting to see the break out past 12p
Broker target are much higher I see
Sales and FDA news is due
Thanks. I see the 10000 dealer is having another go. Why this amount of separate share deals is occuring is strange given that they could buy a lot more than 10000 in one go. Made the SP rise a little though so not complaining if the punter wishes to carry on doing this.
Fair does no worries 😁
Apology Dusthead, I have posted comment on wrong Company. I still have My shares though.. Shows that You have feelings for this Co. Agree with Your comment that a BIG HITTER is now involved. Enjoy time in toilet though.
What`s Your issue dusthead, not had Your Daily W@*K ?
Appointment of new Chief Financial Officer
Canadian life sciences company Ondine Biomedical Inc. (LON: OBI) has appointed Joseph P. ("JP") Errico as Chief Financial Officer.[i] JP will be responsible for managing and developing Ondine's finance function, as well as managing the capital markets interface, participating in discussions with large health systems and customers, and working closely with the management team on overall growth strategy, both from a financial and operational perspective.
JP has successfully founded and sold (or taken public) several medical device and pharmaceutical companies, including ElectroCore, Fastenetix, K2 Medical Systems, AD4-Pharma, E2, and SpineCore, with his patented products generating over $20 billion in sales.
Carolyn Cross, CEO and founder of Ondine commented:
"We are delighted that JP has agreed to join Ondine at this exciting time. His experience in finance, capital markets and developing medtech companies will be invaluable as we move forward with our international expansion and achieving FDA approval in conjunction with our partner HCA Healthcare."
JP Errico commented:
"Ondine represents a unique opportunity to create shareholder value while heading off one of humanity's greatest health threats, antimicrobial resistance. I am proud to be joining an excellent team of professionals as Ondine brings this critically needed technology to the world."
JP's educational background includes an undergraduate degree in Aeronautical Engineering from the Massachusetts Institute of Technology and graduate degrees in both Law and Mechanical/Materials Engineering from Duke University. He is also a trained patent attorney.
*ENDS*
Enquiries:
ROCKETVI
Posted in: OBI
Posts: 825
Price: 9.00
No Opinion
RE: Alliance News today13 Dec 2023 15:16
Hope they have full patents on their technology. This one still under the radar but for how long ? Millions of machines would be required Worldwide when this disinfectant process fully takes off. OBI would make a fortune if they could just get a small % of this market potential. Light fuse and stand well back, it`s coming home....
Lol!!!!!
Then ?
ROCKETVI
Posted in: OBI
Posts: 825
Price: 9.50
No Opinion
RE: Silence16 Jan 2024 15:13
At break even now and this is still under the radar. Multi-bagger in the making.
Your post from a few days ago one more Muppet poster who knows sweet FA
Do you think a big hitter like the cfo comes here on a wimm
You clearly sold at breakeven clooooown do one lolololol
Should be soon as the staff will have to go another Month on previous agreement regarding wages not being paid. Total mess they have made of this relying on payments from a project that is still in development. Maybe they have expanded too quickly with no cash back-up. Can only hope its sorted out before Month`s end with either a payment from customer or a cash injection from another source. Can`t see a fund raise that would include PI`s to be honest. Not my best investment to-date.
What's the timescale on upcoming newsflow any idea
Same buyer for 6 separate 10,000 deals. Hope they know something We dont.
9.695-9.88p
Https://www.marketscreener.com/insider/JOSEPH-ERRICO-A1M2IX/